GCP
CDLX icon

GSA Capital Partners’s Cardlytics CDLX Stock Holding History

GSA Capital Partners’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$276K Sell
26,331
-20,704
-44% -$202K 0.02% 1294
2025
Q4 		$541K Buy
47,035
+35,647
+313% +$551K 0.05% 753
2025
Q3 		$277K Sell
11,388
-24,467
-68% -$408K 0.02% 1246
2025
Q2 		$590K Buy
35,855
+34,124
+1,971% +$589K 0.04% 810
2025
Q1 		$32K Sell
1,731
-29,441
-94% -$841K ﹤0.01% 1568
2024
Q4 		$1.16M Sell
31,172
-7,060
-18% -$270K 0.09% 309
2024
Q3 		$1.22M Buy
38,232
+35,448
+1,273% +$1.97M 0.09% 346
2024
Q2 		$229K Buy
+2,784
New +$301K 0.02% 1410
2024
Q1 		– Sell
-11,736
Closed -$1.08M – 1642
2023
Q4 		$1.08M Buy
11,736
+7,922
+208% +$805K 0.09% 349
2023
Q3 		$629K Sell
3,814
-21,460
-85% -$2.79M 0.05% 652
2023
Q2 		$1.6M Buy
25,274
+22,271
+742% +$1.35M 0.16% 124
2023
Q1 		$102K Sell
3,003
-11,289
-79% -$590K 0.01% 1353
2022
Q4 		$826K Buy
+14,292
New +$883K 0.1% 301
2019
Q4 		– Sell
-703
Closed -$236K – 1459
2019
Q3 		$236K Buy
+703
New +$225K 0.03% 1085

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

GSA Capital Partners's CDLX Position: Q1 2026 in Review

GSA Capital Partners reduced its Cardlytics (CDLX) stake by 44% in Q1 2026, selling an estimated $202K and leaving 26,331 shares worth $276K. The position accounts for 0.02% of the portfolio, ranked #1294.

GSA Capital Partners first reported a position in CDLX in Q3 2019 and has held it in 14 quarters since. The position peaked at $1.6M in Q2 2023. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.

  • GSA Capital Partners held 26,331 shares of Cardlytics worth $276K as of Q1 2026.
  • GSA Capital Partners sold 20,704 Cardlytics shares in Q1 2026, an estimated $202K.
  • Cardlytics made up 0.02% of GSA Capital Partners's portfolio in Q1 2026, its #1294 holding.
  • GSA Capital Partners first reported a position in Cardlytics in Q3 2019 and has held it in 14 quarters since.
  • GSA Capital Partners's Cardlytics position peaked at $1.6M in Q2 2023.
  • 58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.